Abstract: Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.

Abstract: A non-tumorigenic skin care composition is provided.

Abstract: Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.

Abstract: Hair treatment agents that, in addition to at least one hair-setting polymer, additionally contain polyether-modified organic compounds having at least three polyether substituents, the polyethers comprising a polyalkylene chain made up of ethylene oxide units or ethylene oxide units and propylene oxide units, having a maximum proportion of 50 wt % propylene oxide units based on weight of the polyoxyalkylene chain.

Abstract: Hair is treated with a copolymer of an unsaturated ester and a styrene sulphonate monomer to reducing damage to hair caused by subsequent heat treatment. The styrene sulphonate monomer is desirably sodium styrene sulphonate and the unsaturated ester is desirably of an unsaturated monocarboxylic acid, such as (meth)acrylic acid, or dicarboxylic acid, such as maleic acid, and an alcohol, desirably an alkoxylated alcohol such as ethoxylated lanolin alcohol. Formulations for hair treatment generally include from about 0.5 to about 25% by weight of the copolymer.

Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.

Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.

Abstract: The invention relates to the cosmetic use of at least one oxazolin as a depigmenting active ingredient in a depigmenting composition, and to the associated cosmetic treatment method. The invention also relates to the use of at least one oxazolin for preparing an active medicament as a depigmenting agent, and to a depigmenting cosmetic composition comprising at least one oxazolin as a depigmenting active ingredient.

Abstract: Anhydrous sunscreen compositions that include a volatile solvent, an organic UV-filter dissolved in the volatile solvent, a water-insoluble, low-volatility, C2-C8, liquid silicone dissolved in the volatile solvent, a branched fatty acid ester of a polyprotic carboxylic acid dissolved in the volatile solvent, and a film-forming polymer, where the branched fatty acid ester of a polyprotic carboxylic acid and the water-insoluble, low-volatility, C2-C8, liquid silicone are present in a ratio from about 3:1 to 4.25:1.

Abstract: A cosmetic or dermatological preparation which comprises an aluminum containing antiperspirant active ingredient, an ?-hydroxycarboxylic acid, water and optionally, a plurality of particles in a stably suspended state. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.

Abstract: Compositions and methods of using the compositions are provided for forming an embolus within a region of an anatomical lumen for a transitory period in order to achieve a therapeutic effect.

Abstract: An injectable depot formulation comprising crystals having structure (I) wherein R is (FII) and the X50 value of the crystals is from 1 to 200 microns. Depot formulations containing crystals of iloperidone or its metabolites have the following advantages: (i) release of the crystals in plasma can be correlated with the size of the crystals; (ii) absorption of the crystals in plasma can be correlated with the size of the crystals; (iii) the particle size of the crystals can be controlled by crystal engineering and/or milling; and (iv) the crystals are stable upon storage, and stable to sterilization procedures, such as gamma irradiation.

Abstract: The present invention relates to a deodorant cosmetic composition comprising: (a) at least one lipophilic salicylic acid derivative of formula (I) below, or a salt thereof: (b) at least one antiperspirant aluminum salt; in an (a)/(b) weight ratio of less than 1/20. The invention also relates to a cosmetic process for treating human perspiration and human body odor, in particular underarm perspiration and underarm odor, using this composition. The invention relates to the use of a combination of at least (a) one lipophilic salicylic acid derivative of formula (I), or a salt thereof, and of at least (b) one antiperspirant aluminum salt, in an (a)/(b) weight ratio of less than 1/20, as a deodorant active agent in a cosmetic composition.

Abstract: The present invention discloses certain chirally correct polyene cyclodextrin acetals and hemiacetals (formula I) that are effective in providing skin clarification, which is useful for the treatment of acne, and skin disfigurements and skin darkening resulting from acne; skin darkening from cancer, diabetes, radiation treatments, chemotherapy, and sun-burn; mitochondrial and DNA dysfunction; age spots; loss of cellular antioxidants; skin changes associated with aging including collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles and fine lines, oxidation, damage from radiation, damage from free radicals, and damage from UV; dry skin; xerosis; ichthyosis; dandruff; brownish spots; keratoses; melasma; lentigines; liver spots; skin pigmentation including pigmented spots, dark circles under the eyes, darkened skin, and blemishes; oily skin; warts; eczema; pruritic skin; psoriasis; inflammatory dermatoses; topical inflammation; disturbed keratinization; scalp dryness, and combinations th

Abstract: Deodorant or antiperspirant sticks based on an oil-in-water dispersion/emulsion for application on the skin.

Abstract: The present invention discloses a method of treating, reducing the occurrence of, or improving the symptoms associated with a skin condition by topical application of a compound of formula (I) or a salt thereof, wherein said skin condition is selected from the group consisting of melanogenesis, oxidative damage, inflammation, skin irritation from inflammation, loss of cell adhesion, loss of desquamation, extra-cellular including connective tissue matrix breakdown and skin tone loss thereof, loss of keratinization, cellular senescence, skin aging from cellular senescence, loss of skin whiteness, loss of skin barrier function, loss of skin firmness, rosacea, skin wrinkles and fine lines from cellular senescence, cellular oxidation, loss of skin collagen, topical wounds, and combinations thereof.

Abstract: The present invention is drawn to a carrier composition containing: (a) at least one polyamine compound comprising at least two amino groups; (b) at least one nonionic surfactant; (c) at least one anionic silicone; and (d) at least one water-insoluble material, and wherein the composition, when combined with an aqueous phase, forms an aqueous delivery system which is both stable, and clear to slightly hazy/limpid in appearance.

Abstract: Sunscreen composite particles for UVA and UVB protection are described. The particles are substantially free of supplied UVB sunscreen and are prepared with a UVA sunscreen suitable to undergo keto-enol tautomerization.

Abstract: Compositions containing a photoactivable agent and an agent that absorbs or blocks extraneous radiation during phototherapy are useful and used in methods to treat leukocyte mediated autoimmune diseases such as psoriasis, CTCL, and vertiligo.

Abstract: Disclosed is an ultraviolet absorber water-dispersed composition, comprising the following components (A) and (B); (A) a benzotriazole-type ultraviolet absorber represented by general formula (1) below wherein R1 and R2 denote alkyl groups having a carbon number from 1 to 18, may be identical or different, and may be substituted by one or two or more groups selected from the group consisting of alkyl groups having a carbon number from 1 to 4, and cycloalkyl groups and aryl groups both having a carbon number from 5 to 12; and (B) polyglycerol monoalkyl ester with a mean degree of polymerization of glycerol of 5 or more. The water-dispersed composition is capable of stably maintaining the dispersed state of benzotriazole-type ultraviolet absorbers even in the presence of salt.